Every year over 2,200 students graduate with their Bachelor’s in pharmacy eager to make their mark on this industry. How will this new emerging class impact how we interact with our local communities and run our businesses. Most importantly, how can we leverage this new class of talented professionals to meet the impending challenge of Amazon’s expansion.
Dr. Jane Xia joins Pindy on this episode. Dr. Xia has practiced in various areas of pharmacy including community, hospital, regulatory, and industry. She also helped launch the Hepatitis C Screening program at London Drugs. As a faculty member of Pharmaceutical Sciences at UBC, Dr. Xia has compelling thoughts about the changes that are coming.
About Dr. Jane Xia
Dr. Jane Xia joined the Faculty of Pharmaceutical Sciences in January 2019. She obtained her bachelor of science in pharmacy at the University of British Columbia, MBA at Simon Fraser University, and PharmD at the University of Toronto.
Dr. Xia has practiced in various areas of pharmacy including community, hospital, regulatory, and industry. Dr. Xia has built trusting relationships with physicians and other health care professionals while working at Merck and Boehringer-Ingelheim. In 2018, Dr. Xia and her team at London Drugs launched the Hepatitis C Screening Program at selected community pharmacies after establishing strong partnerships with patient advocacy groups, healthcare teams, and specialists. Dr. Xia’s academic areas of interest include patient journeys, interprofessional collaboration, and business in health care. Dr. Xia’s current focus of scholarly research is on the assessment of patient journeys in chronic diseases.